311 related articles for article (PubMed ID: 19223625)
21. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.
Li PC; Jang J; Hsia CY; Groomes PV; Lian W; de Wispelaere M; Pitts JD; Wang J; Kwiatkowski N; Gray NS; Yang PL
ACS Infect Dis; 2019 Mar; 5(3):460-472. PubMed ID: 30608640
[TBL] [Abstract][Full Text] [Related]
22. Epitopes based drug design for dengue virus envelope protein: A computational approach.
Wadood A; Mehmood A; Khan H; Ilyas M; Ahmad A; Alarjah M; Abu-Izneid T
Comput Biol Chem; 2017 Dec; 71():152-160. PubMed ID: 29096381
[TBL] [Abstract][Full Text] [Related]
23. Small molecule inhibitors possibly targeting the rearrangement of Zika virus envelope protein.
Sharma N; Prosser O; Kumar P; Tuplin A; Giri R
Antiviral Res; 2020 Oct; 182():104876. PubMed ID: 32783901
[TBL] [Abstract][Full Text] [Related]
24. Identification of small molecule inhibitors targeting the Zika virus envelope protein.
Pitts J; Hsia CY; Lian W; Wang J; Pfeil MP; Kwiatkowski N; Li Z; Jang J; Gray NS; Yang PL
Antiviral Res; 2019 Apr; 164():147-153. PubMed ID: 30771406
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel target sites and an inhibitor of the dengue virus E protein.
Yennamalli R; Subbarao N; Kampmann T; McGeary RP; Young PR; Kobe B
J Comput Aided Mol Des; 2009 Jun; 23(6):333-41. PubMed ID: 19241120
[TBL] [Abstract][Full Text] [Related]
26. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.
Alhoot MA; Rathinam AK; Wang SM; Manikam R; Sekaran SD
Int J Med Sci; 2013; 10(6):719-29. PubMed ID: 23630436
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors.
Jadav SS; Kaptein S; Timiri A; De Burghgraeve T; Badavath VN; Ganesan R; Sinha BN; Neyts J; Leyssen P; Jayaprakash V
Bioorg Med Chem Lett; 2015 Apr; 25(8):1747-1752. PubMed ID: 25791449
[TBL] [Abstract][Full Text] [Related]
29. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
[TBL] [Abstract][Full Text] [Related]
30. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.
Anasir MI; Ramanathan B; Poh CL
Viruses; 2020 Mar; 12(4):. PubMed ID: 32225021
[TBL] [Abstract][Full Text] [Related]
31. Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells.
Acosta EG; Piccini LE; Talarico LB; Castilla V; Damonte EB
Virus Res; 2014 May; 184():39-43. PubMed ID: 24583230
[TBL] [Abstract][Full Text] [Related]
32. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
[TBL] [Abstract][Full Text] [Related]
33. GNF-2 Inhibits Dengue Virus by Targeting Abl Kinases and the Viral E Protein.
Clark MJ; Miduturu C; Schmidt AG; Zhu X; Pitts JD; Wang J; Potisopon S; Zhang J; Wojciechowski A; Hann Chu JJ; Gray NS; Yang PL
Cell Chem Biol; 2016 Apr; 23(4):443-52. PubMed ID: 27105280
[TBL] [Abstract][Full Text] [Related]
34. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
[TBL] [Abstract][Full Text] [Related]
35. Novel approaches to flavivirus drug discovery.
Botting C; Kuhn RJ
Expert Opin Drug Discov; 2012 May; 7(5):417-28. PubMed ID: 22439769
[TBL] [Abstract][Full Text] [Related]
36. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT
Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425
[TBL] [Abstract][Full Text] [Related]
37. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.
Howe MK; Speer BL; Hughes PF; Loiselle DR; Vasudevan S; Haystead TA
Antiviral Res; 2016 Jun; 130():81-92. PubMed ID: 27058774
[TBL] [Abstract][Full Text] [Related]
38. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
J Mol Graph Model; 2018 Jan; 79():88-102. PubMed ID: 29156382
[TBL] [Abstract][Full Text] [Related]
39. In vitro analysis of synthetic peptides in blocking the entry of dengue virus.
John AM; Jittmittraphap A; Chattanadee S; Alwin Prem Anand A; Shenbagarathai R; Leaungwutiwong P
Virus Res; 2019 Jan; 260():142-150. PubMed ID: 30508603
[TBL] [Abstract][Full Text] [Related]
40. Identification of Zika Virus Inhibitors Using Homology Modeling and Similarity-Based Screening to Target Glycoprotein E.
Telehany SM; Humby MS; McGee TD; Riley SP; Jacobs A; Rizzo RC
Biochemistry; 2020 Oct; 59(39):3709-3724. PubMed ID: 32876433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
